Target intelligence / Profile preview

Cancer cell membrane microdomain

Molecular classification
Other
01

Overview

Cancer cell membrane microdomains, commonly known as lipid rafts, are small, dynamically organized regions within the plasma membrane that are enriched in cholesterol, sphingolipids, and certain proteins such as caveolin and flotillin[1][3][4][5]. They provide specialized platforms for cell signaling, adhesion, migration, endocytosis, and regulation of protein and lipid trafficking, and they play critical roles in the regulation of cancer cell behavior including growth, survival, metastasis, and drug resistance[1][3][4][5]. These microdomains can concentrate or exclude specific signaling molecules, thus modulating the efficacy of receptor-mediated signaling pathways relevant to tumor progression and therapy resistance. While there is intense research focus on targeting the unique properties of cancer cell membrane microdomains to overcome resistance and inhibit metastasis, these microdomains do not represent a single molecular target, but rather a collective functional entity composed of multiple lipids and proteins[1][4][5][6]. Therefore, "Cancer cell membrane microdomain" is not a specific druggable target like a receptor, enzyme, or transporter, but instead a structural principle influencing many potential therapeutic targets.

Other names
Lipid raftMembrane raftLipid microdomainMembrane microdomainCaveola
02

Mechanism of action

Disruption of lipid raft structure to sensitize cancer cells to apoptosis; Targeting cholesterol content and organization to alter membrane protein function; Modulation of raft-associated signaling pathways

03

Biological functions

Signal transductionCell adhesionCell migrationCell proliferationApoptosisDrug resistanceCell death
04

Disease associations

CancerMultidrug resistanceMetastasisTumor progressionOther
05

Safety considerations

Non-specific toxicity due to broad modulation of membrane structure affecting normal cellsPotential interference with essential physiological signalingRisk of enhancing metastasis or invasiveness if not properly targeted
06

Interacting drugs

Statins (e.g. simvastatin)

5 more in the full profile.

07

Biomarkers

Caveolin-1 and Caveolin-2 expressionCD44 and CD24 surface levelsMultidrug resistance transporter (e.g., P-glycoprotein) abundance

Beyond the preview

Go deeper on Cancer cell membrane microdomain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer cell membrane microdomain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call